Robuta

Sponsor of the Day: Jerkmate

https://c19early.org/wijewickrema.html Wijewickrema: Efficacy and safety of oral ivermectin in the treatment of mild to moderate Covid-19... Wijewickrema, 249 patient ivermectin early treatment RCT: 51% improved viral clearance (p=0.03). RCT 249 hospitalized patients with mild to moderate COVID-19..... moderate covid 19 efficacy safety oral ivermectin https://journals.plos.org/globalpublichealth/article?id=10.1371/journal.pgph.0001538 Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy... The soluble urokinase plasminogen activator receptor (suPAR) has been proposed as a biomarker for risk stratification of patients presenting with acute... moderate covid 19 point care analytical validation https://c19early.org/an.html An: Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a... An, 226 patient HCQ late treatment study: 3% faster viral clearance (p=0.92). Retrospective of hospitalized patients with 31 HCQ patients and 195 standard.. -... moderate covid 19 treatment response hydroxychloroquine antibiotics mild https://www.medrxiv.org/content/10.1101/2020.07.04.20146548v1 Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a... Objectives To assess the efficacy of hydroxychloroquine on mild-moderate COVID-19 patients in South Korea. Methods A retrospective cohort study of the 358... moderate covid 19 treatment response hydroxychloroquine antibiotics mild https://c19early.org/mohan.html RIVET-COV: Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): a single-centre... Mohan, 157 patient ivermectin early treatment RCT: 62% improved recovery (p=0.27) and 24% improved viral clearance (p=0.18). RCT in India with low risk.. -... moderate covid 19 single dose rivet oral ivermectin https://www.medrxiv.org/content/10.1101/2022.06.10.22276252v2.supplementary-material Ivermectin for Treatment of Mild-to-Moderate COVID-19 in the Outpatient Setting: A Decentralized,... Background The effectiveness of ivermectin to shorten symptom duration or prevent hospitalization among outpatients in the United States with mild-to-moderate... moderate covid 19 ivermectin treatment mild outpatient https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32105 Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind... moderate covid 19 potential treatment double blind evaluation ivermectin https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1139046/full Frontiers | Efficacy and safety of single-dose ivermectin in mild-to-moderate COVID-19: the... Apr 28, 2026 - Background To investigate whether ivermectin inhibits SARS CoV 2 proliferation in patients with mild-to-moderate COVID-19 using time to a negative COVID-19 r... moderate covid 19 single dose frontiers efficacy safety https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/32105/21639 View of Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A... moderate covid 19 potential treatment view evaluation ivermectin